Exact Mass: 333.06306800000004

Exact Mass Matches: 333.06306800000004

Found 53 metabolites which its exact mass value is equals to given mass value 333.06306800000004, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

3-[(2-Chlorobenzylidene)amino]-6H-dibenzo[b,d]pyran-6-one

C20H12ClNO2 (333.0556522)

Robenidine

1-[(E)-[(4-chlorophenyl)methylidene]amino]-3-[(Z)-[(4-chlorophenyl)methylidene]amino]guanidine

C15H13Cl2N5 (333.0547958)

D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents Antiprotozoal, coccidiostat for poultry and rabbits Robenidine is a coccidiostat

Bromodiphenhydramine

2-(p-Bromo-alpha-phenylbenzyloxy)-N,N-dimethylethylamine

C17H20BrNO (333.07281700000004)

Bromodiphenhydramine is only found in individuals that have used or taken this drug. It is an ethanolamine antihistamine with antimicrobial property. Bromodiphenhydramine is used in the control of cutaneous allergies. Ethanolamine antihistamines produce marked sedation in most patientsBromodiphenhydramine competes with free histamine for binding at HA-receptor sites. This antagonizes the effects of histamine on HA-receptors, leading to a reduction of the negative symptoms brought on by histamine HA-receptor binding. R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AA - Aminoalkyl ethers C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist

N-Demethyloxysanguinarine

C19H11NO5 (333.0637196)

Maybridge4_004643

C16H16ClN3OS (333.0702556)

Robenidine

Robenidine hydrochloride

C15H13Cl2N5 (333.0547958)

D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent CONFIDENCE standard compound; INTERNAL_ID 1193 CONFIDENCE standard compound; INTERNAL_ID 1093

Norzotepine sulfoxide

C17H16ClNO2S (333.0590226)

Bromodiphenhydramine

C17H20BrNO (333.07281700000004)

Robenz

3-[(E)-[(4-chlorophenyl)methylidene]amino]-1-[(Z)-[(4-chlorophenyl)methylidene]amino]guanidine

C15H13Cl2N5 (333.0547958)

D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents

GSK1059615

(Z)-5-((4-(pyridin-4-yl)quinolin-6-yl)methylene)thiazolidine-2,4-dione

C18H11N3O2S (333.0571946)

C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor

Thiazolidine, 3-(methylsulfonyl)-2-(2,4,5-trimethoxyphenyl)- (9CI)

C13H19NO5S2 (333.0704604)

3-BROMO-2-(((TERT-BUTYLDIMETHYLSILYL)OXY)METHYL)-6-FLUOROANILINE

C13H21BrFNOSi (333.0559728)

4-(pyridin-2-ylmethyl)-2,3-dihydro-1H-quinoxaline

C14H18Cl3N3 (333.0566238)

4-(pyridin-4-ylmethyl)-2,3-dihydro-1H-quinoxaline

C14H18Cl3N3 (333.0566238)

N-(4-TRIFLUOROMETHYL)PHENYL-3-TRIFLUOROMETHYLBENZAMIDE

C15H9F6NO (333.0588296)

N-[4-(TRIFLUOROMETHYL)PHENYL]-4-(TRIFLUOROMETHYL)BENZAMIDE

C15H9F6NO (333.0588296)

N-(ADAMANTAN-1-YL)-4-BROMOBENZAMIDE

C17H20BrNO (333.07281700000004)

2-[[(2,4-Difluorophenyl)-2-oxiranyl]methyl]-1H-1,2,4-triazole methanesulfonate

C12H13F2N3O4S (333.05948020000005)

1-(3-Bromo-5-methylpyridin-2-yl)-4-propylpiperazine hydrochloride

C13H21BrClN3 (333.06072760000006)

2-(3-Bromo-2-oxopropyl)-3-methoxy-1-piperidinecarboxylic acid 2-propenyl ester

C13H20BrNO4 (333.0575620000001)

boc-(s)-3-amino-3-(2,4-dichloro-phenyl)-propionic acid

C14H17Cl2NO4 (333.0534582000001)

potassium (4-cbz-aminophenyl)trifluoroborate

C14H12BF3KNO2 (333.0550218)

N,N-Bis(4-chlorobenzyl)-1H-1,2,3,4-tetraazol-5-amine

C15H13Cl2N5 (333.0547958)

4-[1-(2,6-Dichlorobenzyl)-2-Methyl-1h-Imidazol-4-Yl]pyrimidin-2-Amine

C15H13Cl2N5 (333.0547958)

N-(4-chloro-2-fluorophenyl)-6,7-dimethoxyquinazolin-4-amine

C16H13ClFN3O2 (333.068028)

Ethanamine, 2-((R)-(4-bromophenyl)phenylmethoxy)-N,N-dimethyl-

C17H20BrNO (333.07281700000004)

2-{3-nitroanilino}-N-({5-nitro-2-furyl}methylene)acetohydrazide

C13H11N5O6 (333.0709306)

Ethanamine, 2-((S)-(4-bromophenyl)phenylmethoxy)-N,N-dimethyl-

C17H20BrNO (333.07281700000004)

1-(5-Chloro-2,4-Dimethoxyphenyl)-3-(5-Cyanopyrazin-2-Yl)urea

C14H12ClN5O3 (333.06286320000004)

d-[3-Hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl]-n,o-cycloserylamide

C11H16N3O7P (333.0725836)

(2R)-2,3-dihydroxypropyl (1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl phosphate

C9H18O11P- (333.0586708)

8-O-methyl-13-carboxynorjavanicin

C16H13O8- (333.0610398)

3-Pyridinecarboxylic acid [2-(2-furanyl)-4-oxo-1-benzopyran-3-yl] ester

C19H11NO5 (333.0637196)

N-(4-chloro-2-fluorophenyl)-3-(methoxymethyl)-2-benzofurancarboxamide

C17H13ClFNO3 (333.0567950000001)

2-(1H-benzimidazol-2-ylthio)-N-(5-propyl-1,3,4-thiadiazol-2-yl)acetamide

C14H15N5OS2 (333.071798)

2-Chloro-5-methyl-1-oxo-3-phenyl-4-pyrido[1,2-a]benzimidazolecarbonitrile

C19H12ClN3O (333.0668852)

bromazine

C17H20BrNO (333.07281700000004)

R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AA - Aminoalkyl ethers C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist

1-(sn-glycero-3-O-phosphonato)-1D-myo-inositol

C9H18O11P (333.0586708)

An inositol phosphate oxoanion obtained by deprotonation of the free phosphate OH group of 1-(sn-glycero-3-phospho)-1D-myo-inositol; major species at pH 7.3.

{3-[(2r,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-2,6-dioxopyrimidin-1-yl}sulfanylcarbamic acid

C11H15N3O7S (333.06306800000004)